Author

Jonas Baumgarten

Primary ORCID profile (0009-0001-8175-3631 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Jonas BaumgarteniD1 paper · University of Turku

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Alexander A. WurmiD· 1 shared Annika Seiler· 1 shared Claudia R. BalliD· 1 shared Elahe Rahimian· 1 shared Frank BuchholziD· 1 shared Hanno GlimmiD· 1 shared Helen Rothfuß· 1 shared Li Ding· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexander A. WurmORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivNov 15, 2023

The histone modifier KAT2A presents a selective target in a subset of well-differentiated microsatellite-stable colorectal cancers

Vida Kufrin, Annika Seiler, Silke Brilloff…·Alexander A. Wurm

This study identifies KAT2A as a therapeutic target in a subset of well-differentiated, microsatellite-stable colorectal cancers by showing its dependency and functional consequences.

DOI 10.1038/s41418-025-01479-7

humanDNA methylation

𝕏 PostBluesky